Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGRM-001 for Knee Osteoarthritis
NCT05288725Phase 2Unknown
- Sponsor
- Next Generation Regenerative Medicine
- Start
- Aug 2022
- Primary completion
- Jun 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of NGRM-001 in knee osteoarthritis (OA), sponsored by Next Generation Regenerative Medicine. Status: unknown.
02
Drugs
NGRM-001
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05288725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05288725.